Our Wegovy and Mounjaro price changes: what you need to know

Ready to take the next step? See if you're eligible for expert-led weight loss support.

Check your eligibility

We've reviewed our prices following market changes. Now, some will pay less and some more. See how it affects you and what your options are.

We've reviewed our prices following market changes. Now, some will pay less and some more. See how it affects you and what your options are.

You might have heard about the recent Mounjaro price increases. On 1 September 2025, Mounjaro's manufacturer, Eli Lilly, raised the wholesale price of Mounjaro in the UK. This price hike has led many providers to raise prices for customers, too.


At SemaPen, we froze the price of Mounjaro and absorbed most of the cost instead. Throughout September, new customers have paid £159 for a starting (2.5mg) dose.


We kept the price at this level because we wanted to give you plenty of time to choose what to do next. After all, it's not fair to rush you when you're making a decision that could affect your health and weight.


However, the offer couldn't last forever. We've reviewed our pricing again and, like nearly all UK suppliers, have taken the difficult decision to change our prices in line with market conditions.


What are the new prices?


As of 1st October, our new prices are as follows:


  • Mounjaro costs £225 for the starting dose (0.25mg).
  • Wegovy costs £189 for the starting dose (2.5mg).


As before, the price you pay changes as you step up your dose. Here's how the new prices look, month by month:

Mounjaro


Month 1 (2.5mg):  £225

Month 2 (5mg):  £225

Month 3 (7.5mg):  £299

Month 4 (10mg):  £299

Month 5 onwards (12.5mg): £349

Wegovy


Month 1 (0.25mg): £189

Month 2 (0.5mg):  £189

Month 3 (1mg):  £189

Month 4 (1.7mg):  £289

Month 5 onwards (2.4mg):  £289

That means 12 months of treatment with Mounjaro now costs £3,840. Previously, it cost £3,290.


Why have Wegovy prices increased, too?


We've increased the starting price of Wegovy from £129 to £189.


However, we've also tweaked the price for each dose that follows. With our new, simplified pricing, long-term treatment with Wegovy is actually cheaper than it was before


Previously, 12 months of Wegovy cost you £3,238. Now, it costs £3,168.


That's a saving of £70 on the old price – and £672 less than 12 months of Mounjaro.


What are my options?


We know it's frustrating when our prices change. But the important thing is that you're free to make the best decision for you.


If you subscribe to our Mounjaro programme, you can choose to:


  • Carry on with the new pricing: we'll send your next dose as normal at the new price.
  • Switch to Wegovy: talk to your SemaPen team and we'll arrange a fast-track medication review. If Wegovy is suitable for you, we'll switch you to Wegovy and you'll pay Wegovy prices from your next dose.
  • Cancel your subscription: while we'd love you to continue your weight loss journey with SemaPen, you're free to cancel your subscription at any time.*


The same is true if you're a Wegovy subscriber. But don't forget that Wegovy now costs less in the long run compared to the old pricing.


Which medication offers the best value for me?


Remember that Wegovy yields an average weight loss of around 15%.¹ With Mounjaro, it's approximately 21%.²


That extra 6% of weight loss might be more cost-effective for some people than others. As an example:


  • If you started at 150kg, you could expect to lose 7kg more with Mounjaro. It would cost you around £17 more per kilogramme.
  • If you started at 90kg, you could expect to lose 4kg more with Mounjaro. It would cost you around £31 more per kilogramme.


Want to see what you could expect to lose – and how much you'd pay per kilogramme for each drug? Try our Wegovy vs Mounjaro cost and weight loss calculator below.

Drag the slider to your start weight
After 12 months

If you have any questions about our price changes, please don't hesitate to get in touch with the SemaPen team.


Sources and small print


1. Wilding, J.P.H. et al. (2021) "Once-weekly semaglutide in adults with overweight or obesity" The New England Journal of Medicine, 384(11) https://doi.org/10.1056/NEJMoa2032183


2. Jastreboff, A.M. et al. (2022) "Tirzepatide Once Weekly for the Treatment of Obesity" The New England Journal of Medicine, 387(3) https://doi.org/10.1056/NEJMoa2206038


* An admin fee may apply for early cancellation. See our terms and conditions.

  • Average 15-21% weight loss*
  • Tailored programmes built by real experts
  • Targeted support to make success feel simpler
  • Unique app with weight loss tools and lessons

Your journey starts here

Start your personalised weight loss plan in minutes.

1

Start your online consultation

2

Get approved by our clinical team

3

Begin your programme

Get started
While Wegovy and Mounjaro cause some muscle loss, there are as many myths as facts floating around.
by Simon Edward 25 May 2026
While Wegovy and Mounjaro cause some muscle loss, there are as many myths as facts floating around. Learn what one medical doctor has to say.
Discover what HDL cholesterol is, why it's considered 'good',
by Simon Edward 22 May 2026
Discover what HDL cholesterol is, why it's considered 'good', and how healthy lifestyle changes can support heart health.
How does metabolism influence weight loss? Learn about metabolic rate, calorie balance
by Simon Edward 18 May 2026
How does metabolism influence weight loss? Learn about metabolic rate, calorie balance and how to support your metabolism effectively.
Learn what foods to avoid and what to focus on with Mounjaro and Wegovy, including tips to support
by Simon Edward 15 May 2026
Learn what foods to avoid and what to focus on with Mounjaro and Wegovy, including tips to support safe, sustainable results.
The NHS has announced that 1.2 million more patients in England will be eligible for semaglutide
by Simon Edward 11 May 2026
The NHS has announced that 1.2 million more patients in England will be eligible for semaglutide by summer. Learn the facts behind the headline.
A new study suggests GLP-1 drugs like Mounjaro may improve asthma symptoms
by Simon Edward 8 May 2026
A new study suggests GLP-1 drugs like Mounjaro may improve asthma symptoms for those living with obesity. Join us as we unpack the results.
Wegovy patents are expiring in some parts of the world.
by Simon Edward 1 May 2026
Wegovy patents are expiring in some parts of the world. Does that mean we'll soon see cheaper generic versions in the UK?
In 2025, Novo Nordisk announced disappointing results from its semaglutide Alzheimer's trial.
by Simon Edward 1 May 2026
In 2025, Novo Nordisk announced disappointing results from its semaglutide Alzheimer's trial. But that's not the end of the story. Find out why.
Have you been told you're ineligible for weight loss drugs? Learn about your options and your rights
by Simon Edward 1 May 2026
Have you been told you're ineligible for weight loss drugs? Learn about your options and your rights, including asking for a second opinion on the NHS.
What's the safest way to dispose of weight loss pens and needles? Learn proper disposal methods
by Simon Edward 1 May 2026
What's the safest way to dispose of weight loss pens and needles? Learn proper disposal methods for Mounjaro and Wegovy in our UK guide.
More posts